Patent Update: Central & Peripheral Nervous Systems: Antimigraine agents: July 1994 - June 1995

Abstract

The patent literature pertaining to agents for the treatment of migraine headache and related disorders has been reviewed for the period of July 1, 1994 to June 30, 1995. Included are patents on serotonergic agents, i.e. 5-HT_1D agonists, 5-HT₂ receptor ligands and 5-HT₃ antagonists as well as patents disclosing chemical entities claimed to have potential antimigraine activity via non-serotonergic mechanisms, e.g. tachykinin receptor antagonists and nitric oxide synthetase inhibitors. Relevant references from the recent scientific literature have also been cited.